Global Multiple Sclerosis Drugs Market Sales to Top US$ 41 Billion by 2033; CAGR of 3.8% New York, May 12, 2023 (GLOBE NEWSWIRE) -- According to Market.us, the global Multiple Sclerosis Drugs Market is estimated to be valued at USD 41 Billion by 2032 and is expected to exhibit a CAGR of...